Clinical Trial Update: Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2) [Phase 3]

View source ↗

Summary

Phase 3 trial ENLIGHTEN 2 evaluating LYR-210 for chronic rhinosinusitis in adults has completed and results have been posted. The update summarizes efficacy and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis
• Sinusitis

Drugs mentioned

• LYR-210

Snippet

Sponsor: Lyra Therapeutics | Conditions: Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Phase 3 | Status: COMPLETED | Results posted: 2026-02-19